Maolac
7 known investors
Find your way into Maolac
Sign up to see every warm intro you have to Maolac
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Maolac team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Maolac develops colostrum-based functional ingredients optimized for human biology using proprietary AI that selects proteins structurally similar to human proteins. Its clinically validated ingredients, effective at low daily doses, target gut health, recovery, healthy aging, and skin for use in supplements and formulations.
Investors · 7
How we know: New Gate Capital's portfolio page · Not right? Tell us
How we know: globes.co.il · Not right? Tell us
How we know: globes.co.il · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements- Undisclosed amountseed funding roundAug 2022
OurCrowd (lead), Mediterranean Towers Ventures, NEOME, The Food Tech Lab, The Kitchen FoodTech Hub, VentureIsrael
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Maolac do?
- Maolac develops colostrum-based functional ingredients optimized for human biology using proprietary AI that selects proteins structurally similar to human proteins. Its clinically validated ingredients, effective at low daily doses, target gut health, recovery, healthy aging, and skin for use in supplements and formulations.
- Who are Maolac's investors?
- Maolac's investors include New Gate Capital, Mediterranean Towers Ventures, OurCrowd, VentureIsrael.


